 |
 |
----- Oorspronkelijk bericht ----- Van: "Marjorie L. Moorefield" <[log in to unmask]> Aan: <[log in to unmask]> Verzonden: vrijdag 8 september 2000 3:04 Onderwerp: DOPASCAN Hi Marjorie, >> Guilford entered into a corporate collaboration with Daiichi Radioisotope Laboratories (DRL) in December, 1995 for the commercialization of DOPASCAN® Injection in Japan, Korea, and Taiwan. DRL plans to initiate a Phase III clinical trial of DOPASCAN® Injection in the second half of 2000. This is the second half of 2000, so maybe they are having more trials, but I can't seem to find it. << I could not find it either, so I sent an email to Guilford, requesting an update regarding the DOPASCAN. Hans.